Literature DB >> 20008691

A comparison of prediction models for fractures in older women: is more better?

Kristine E Ensrud1, Li-Yung Lui, Brent C Taylor, John T Schousboe, Meghan G Donaldson, Howard A Fink, Jane A Cauley, Teresa A Hillier, Warren S Browner, Steven R Cummings.   

Abstract

BACKGROUND: A Web-based risk assessment tool (FRAX) using clinical risk factors with and without femoral neck bone mineral density (BMD) has been incorporated into clinical guidelines regarding treatment to prevent fractures. However, it is uncertain whether prediction with FRAX models is superior to that based on parsimonious models.
METHODS: We conducted a prospective cohort study in 6252 women 65 years or older to compare the value of FRAX models that include BMD with that of parsimonious models based on age and BMD alone for prediction of fractures. We also compared FRAX models without BMD with simple models based on age and fracture history alone. Fractures (hip, major osteoporotic [hip, clinical vertebral, wrist, or humerus], and any clinical fracture) were ascertained during 10 years of follow-up. Area under the curve (AUC) statistics from receiver operating characteristic curve analysis were compared between FRAX models and simple models.
RESULTS: The AUC comparisons showed no differences between FRAX models with BMD and simple models with age and BMD alone in discriminating hip (AUC, 0.75 for the FRAX model and 0.76 for the simple model; P = .26), major osteoporotic (AUC, 0.68 for the FRAX model and 0.69 for the simple model; P = .51), and clinical fracture (AUC, 0.64 for the FRAX model and 0.63 for the simple model; P = .16). Similarly, performance of parsimonious models containing age and fracture history alone was nearly identical to that of FRAX models without BMD. The proportion of women in each quartile of predicted risk who actually experienced a fracture outcome did not differ between FRAX and simple models (P > or = .16).
CONCLUSION: Simple models based on age and BMD alone or age and fracture history alone predicted 10-year risk of hip, major osteoporotic, and clinical fracture as well as more complex FRAX models.

Entities:  

Mesh:

Year:  2009        PMID: 20008691      PMCID: PMC2811407          DOI: 10.1001/archinternmed.2009.404

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  30 in total

1.  Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide.

Authors:  Kevin McGeechan; Petra Macaskill; Les Irwig; Gerald Liew; Tien Y Wong
Journal:  Arch Intern Med       Date:  2008-11-24

Review 2.  Epidemiology and outcomes of osteoporotic fractures.

Authors:  Steven R Cummings; L Joseph Melton
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

3.  Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

Authors:  M R McClung; P Geusens; P D Miller; H Zippel; W G Bensen; C Roux; S Adami; I Fogelman; T Diamond; R Eastell; P J Meunier; J Y Reginster
Journal:  N Engl J Med       Date:  2001-02-01       Impact factor: 91.245

4.  Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines.

Authors:  Meghan G Donaldson; Peggy M Cawthon; Li-Yung Lui; John T Schousboe; Kristine E Ensrud; Brent C Taylor; Jane A Cauley; Teresa A Hillier; Dennis M Black; Doug C Bauer; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

5.  Smoking and fracture risk: a meta-analysis.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; C De Laet; J A Eisman; S Fujiwara; H Kroger; E V McCloskey; D Mellstrom; L J Melton; H Pols; J Reeve; A Silman; A Tenenhouse
Journal:  Osteoporos Int       Date:  2004-06-03       Impact factor: 4.507

Review 6.  Diagnosis of osteoporosis and assessment of fracture risk.

Authors:  John A Kanis
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

7.  A meta-analysis of prior corticosteroid use and fracture risk.

Authors:  John A Kanis; Helena Johansson; Anders Oden; Olof Johnell; Chris de Laet; L Joseph Melton III; Alan Tenenhouse; Jonathan Reeve; Alan J Silman; Huibert A P Pols; John A Eisman; Eugene V McCloskey; Dan Mellstrom
Journal:  J Bone Miner Res       Date:  2004-01-27       Impact factor: 6.741

Review 8.  Communicating evidence for participatory decision making.

Authors:  Ronald M Epstein; Brian S Alper; Timothy E Quill
Journal:  JAMA       Date:  2004-05-19       Impact factor: 56.272

9.  FRAX and risk of vertebral fractures: the fracture intervention trial.

Authors:  Meghan G Donaldson; Lisa Palermo; John T Schousboe; Kristine E Ensrud; Marc C Hochberg; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

10.  Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study.

Authors:  E V McCloskey; H Johansson; A Oden; S Vasireddy; K Kayan; K Pande; T Jalava; J A Kanis
Journal:  Osteoporos Int       Date:  2008-11-11       Impact factor: 4.507

View more
  58 in total

1.  Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes.

Authors:  Ann V Schwartz; Eric Vittinghoff; Douglas C Bauer; Teresa A Hillier; Elsa S Strotmeyer; Kristine E Ensrud; Meghan G Donaldson; Jane A Cauley; Tamara B Harris; Annemarie Koster; Catherine R Womack; Lisa Palermo; Dennis M Black
Journal:  JAMA       Date:  2011-06-01       Impact factor: 56.272

2.  Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.

Authors:  J Tamaki; M Iki; E Kadowaki; Y Sato; E Kajita; S Kagamimori; Y Kagawa; H Yoneshima
Journal:  Osteoporos Int       Date:  2011-01-29       Impact factor: 4.507

3.  Fracture-risk calculators: Has their time come?

Authors:  Mark J Bolland
Journal:  CMAJ       Date:  2010-12-20       Impact factor: 8.262

4.  Bone mineral density testing: too much of a good thing?

Authors:  Christina Korownyk; G Michael Allan; Michael R Kolber
Journal:  Can Fam Physician       Date:  2010-12       Impact factor: 3.275

5.  Predicting hip and major osteoporotic fractures using administrative data.

Authors:  Huifeng Yun; Elizabeth Delzell; Kristine E Ensrud; Meredith L Kilgore; David Becker; Michael A Morrisey; Jeffrey R Curtis
Journal:  Arch Intern Med       Date:  2010-11-22

6.  Predictive value of FRAX for fracture in obese older women.

Authors:  Melissa Premaor; Richard A Parker; Steve Cummings; Kris Ensrud; Jane A Cauley; Li-Yung Lui; Theresa Hillier; Juliet Compston
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

Review 7.  How to predict the risk of fracture in HIV?

Authors:  Michael T Yin; Julian Falutz
Journal:  Curr Opin HIV AIDS       Date:  2016-05       Impact factor: 4.283

8.  Predicting fractures in an international cohort using risk factor algorithms without BMD.

Authors:  Philip N Sambrook; Julie Flahive; Fred H Hooven; Steven Boonen; Roland Chapurlat; Robert Lindsay; Tuan V Nguyen; Adolfo Díez-Perez; Johannes Pfeilschifter; Susan L Greenspan; David Hosmer; J Coen Netelenbos; Jonathan D Adachi; Nelson B Watts; Cyrus Cooper; Christian Roux; Maurizio Rossini; Ethel S Siris; Stuart Silverman; Kenneth G Saag; Juliet E Compston; Andrea LaCroix; Stephen Gehlbach
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

9.  One-leg standing time and hip-fracture prediction.

Authors:  H Lundin; M Sääf; L-E Strender; S Nyren; S-E Johansson; H Salminen
Journal:  Osteoporos Int       Date:  2014-02-22       Impact factor: 4.507

10.  The added value of trabecular bone score to FRAX® to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.

Authors:  Y Su; J Leung; D Hans; O Lamy; T Kwok
Journal:  Osteoporos Int       Date:  2016-08-26       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.